Has Samir Rao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,723 in general payments to Samir Rao, MD across 204 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samir Rao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samir Rao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samir Rao, MD

Plastic Surgery · Chevy Chase, MDNPI 1710111885

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (45.5%), gifts and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by AbbVie at 59.8% of the total. Reporting peaked in 2019 at $16,564 and has fallen 90.8% since, to $1,525 in 2025. Among plastic surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,723in general payments, 2019–2025

Across 204 payments — averaging $126.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$15K
Sientra, Inc.$4K
Axogen$3K
Motiva USA, LLC$641
Integra Lifesciences Corporation$527
Bard Peripheral Vascular, Inc.$513
plus $2K from 14 others

What the payments were for

Consulting fees$2,74111%
Travel & lodging$1,6777%
Food & beverage$11,71146%
Gifts$9,59537%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	126	$15,393
Sientra, Inc.	7	$3,712
Axogen	14	$2,567
Motiva USA, LLC	6	$641
Integra Lifesciences Corporation	7	$527
Bard Peripheral Vascular, Inc.	11	$513
Mentor Worldwide LLC	9	$444
Smith+Nephew	3	$417
Baxter Healthcare	3	$304
Davol Inc.	3	$224
Myriad Genetic Laboratories, Inc.	2	$221
Tepha Inc	3	$174
Musculoskeletal Transplant Foundation Inc.	1	$166
TELA Bio, Inc.	2	$133
Stryker	2	$110
Innovation Technologies Inc	1	$88
Coopersurgical, Inc.	1	$38
Pacira Pharmaceuticals Incorporated	1	$19
Biocircuit Technologies Inc	1	$18
Galderma Laboratories, L.p.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NATRELLE$11,004
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$3,609
AxoGuard Nerve Protector$1,930
AxoGuard Nerve Connector$1,930
NATRELLE SALINE-FILLED BREAST IMPLANTS$1,761
ALLODERM$482
AVANCE NERVE GRAFT$385
Motiva Implant Matrix$325
myRisk$221
TENOGLIDE$181
DuraSorb Monofilament Mesh$152
Oasis$151
ARTISS$146
Phasix Mesh$141
BOTOX$136
Grafix$136
No Related Product$133
MENTOR SILTEX Round SPECTRUM$131
Stravix$130
GRAFIX PL$130

How this compares

$25,723 in reported general payments places this provider in the 90th percentile of 105 plastic surgery providers in Maryland.

See all plastic surgery providers in Maryland →

Medicare billing

Part B allowed, 2024

$30,425

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	13	$93
Ondansetron OdtOndansetron	11	$41
Cephalexin	15	$29

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Chevy Chase

Frank AlbinoChevy Chase$25K
Navin SinghChevy Chase$16K
Ornela KutzkeChevy Chase$5K
James BrunoChevy Chase$5K
Christopher BrownChevy Chase$4K
Sheilah LynchChevy Chase$2K
Wendell MilesChevy Chase$2K
Chad GordonBaltimore$2.9M
Larry LicksteinTowson$271K
Sarah MessColumbia$178K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →